Up-regulation of Fas ligand and down-regulation of Fas expression in oral carcinogenesis

被引:33
|
作者
Chen, QM [1 ]
Samaranayake, LP
Zhen, X
Luo, G
Nie, MH
Li, BQ
机构
[1] Univ Hong Kong, Oral Biosci Labs, Fac Dent, Hong Kong, Peoples R China
[2] W China Univ Med Sci, Coll Stomatol, Chengdu, Peoples R China
关键词
Fas; FasL; oral; premalignant lesions; squamous cell carcinoma;
D O I
10.1016/S1368-8375(99)00029-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
An important molecule involved in delivering the death signal that initiates apoptosis is called Fas, or Apo-1, which sits on the cell surface. When another molecule called the Fas ligand (FasL) binds to it, Fas triggers a series of events inside the cell that leads to apoptosis. In order to investigate the mechanism of immune escape and the expression of Pas and Fast in oral premalignant lesions (OPLs) and oral squamous cell carcinomas (OSCCs), a total of 64 samples were evaluated by an immunohistochemical method using a labelled streptavidin-biotin assay. These samples comprised nine hyperkeratotic and 24 oral premalignant lesions (nine of mild, moderate, and six of severe dysplastic lesions), and 24 OSCCs, together with seven healthy controls. The results demonstrated that the majority of invasive OSCCs showed down-regulation of Fas expression but up-regulation of Fast expression. These phenomena were also detected in OPLs. The results indicate that the expression of Fas and FasL is involved in oral carcinogenesis and this may be a mechanism by which the cancer cells evade the host immune assault. Perhaps, in future, Fas/FasL system may be used as a prognostic biomarker in predicting the behavior of oral premalignant lesions. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:548 / 553
页数:6
相关论文
共 50 条
  • [41] Chronic morphine induces up-regulation of the pro-apoptotic Fas receptor and down-regulation of the anti-apoptotic Bcl-2 oncoprotein in rat brain
    Boronat, MA
    García-Fuster, MJ
    García-Sevilla, JA
    BRITISH JOURNAL OF PHARMACOLOGY, 2001, 134 (06) : 1263 - 1270
  • [42] Gene expression data displaying up-regulation and down-regulation of amino acid nutritional metabolic modules
    Li, Jing
    2010 4TH INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICAL ENGINEERING (ICBBE 2010), 2010,
  • [43] Regulation of FAS ligand expression by chemokine ligand 2 in human endometrial cells
    Selam, Belgin
    Kayisli, Umit A.
    Akbas, G. Eda
    Basar, Murat
    Arici, Aydin
    BIOLOGY OF REPRODUCTION, 2006, 75 (02) : 203 - 209
  • [44] Down-regulation of mTOR leads to up-regulation of osteoprotegerin in bone marrow cells
    Mogi, Makio
    Kondo, Ayami
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 384 (01) : 82 - 86
  • [45] Down-regulation of topoisomerase IIα is caused by up-regulation of GRP78
    Gosky, D
    Chatterjee, S
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 300 (02) : 327 - 332
  • [46] Redox regulation of Fas-induced apoptosis and Fas ligand expression in human natural killer cells
    Furuke, K
    Bloom, ET
    FASEB JOURNAL, 1999, 13 (05): : A963 - A963
  • [47] TNF-α and IFN-γ render microglia sensitive to Fas ligand-induced apoptosis by induction of Fas expression and down-regulation of Bcl-2 and Bcl-xL
    Spanaus, KS
    Schlapbach, R
    Fontana, A
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1998, 28 (12) : 4398 - 4408
  • [48] Regulation of Fas and Fas-ligand expression in NK cells by cytokines and the involvement of Fas-ligand in NK/LAK cell-mediated cytotoxicity
    Medvedev, AE
    Johnsen, AC
    Haux, J
    Steinkjer, B
    Egeberg, K
    Lynch, DH
    Sundan, A
    Espevik, T
    CYTOKINE, 1997, 9 (06) : 394 - 404
  • [49] Expression of Fas ligand is an early event in colorectal carcinogenesis
    Shimoyama, M
    Kanda, T
    Liu, LL
    Koyama, Y
    Suda, T
    Sakai, Y
    Hatakeyama, K
    JOURNAL OF SURGICAL ONCOLOGY, 2001, 76 (01) : 63 - 68
  • [50] Apoptosis associated with ex vivo down-regulation of Bcl-2 and up-regulation of Fas in potential cytotoxic CD8(+) T lymphocytes during HIV infection
    Boudet, F
    Lecoeur, H
    Gougeon, ML
    JOURNAL OF IMMUNOLOGY, 1996, 156 (06): : 2282 - 2293